Health ❯Public Health ❯Disease Prevention

COVID-19

Vaccination Vaccine Development Regulatory Affairs Vaccine Development Vaccines Infectious Diseases Vaccines Patient Safety Disease Prevention

3 ARTICLES

last mo.

FDA approves Moderna’s mNEXSPIKE vaccine for seniors and high-risk Americans

Phase 3 data showed the new booster provided stronger protection than Moderna’s original shot, with distribution set for the 2025–2026 respiratory season.